These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 15780739
1. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Fonseca MO, Pang LW, de Paula Cavalheiro N, Barone AA, Heloisa Lopes M. Vaccine; 2005 Apr 22; 23(22):2902-8. PubMed ID: 15780739 [Abstract] [Full Text] [Related]
2. [Efficacy of vaccination against hepatitis B in adult with HIV infection]. Kalinowska-Nowak A, Bociaga-Jasik M, Garlicki A, Mach T. Przegl Epidemiol; 2007 Apr 22; 61(2):339-47. PubMed ID: 17956052 [Abstract] [Full Text] [Related]
3. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults. Potsch DV, Camacho LA, Tuboi S, Villar LM, Miguel JC, Ginuíno C, Silva EF, Mendonça RM, Moreira RB, Barroso PF. Vaccine; 2012 Sep 07; 30(41):5973-7. PubMed ID: 22828589 [Abstract] [Full Text] [Related]
4. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects. Potsch DV, Oliveira ML, Ginuíno C, Miguel JC, Oliveira SA, Silva EF, Moreira RB, Cruz GV, Oliveira AL, Camacho LA, Barroso PF. Vaccine; 2010 Feb 10; 28(6):1447-50. PubMed ID: 19995540 [Abstract] [Full Text] [Related]
5. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults. Bailey CL, Smith V, Sands M. Int J Infect Dis; 2008 Nov 10; 12(6):e77-83. PubMed ID: 18723381 [Abstract] [Full Text] [Related]
6. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania. Pippi F, Bracciale L, Stolzuoli L, Giaccherini R, Montomoli E, Gentile C, Filetti S, De Luca A, Cellesi C. HIV Med; 2008 Aug 10; 9(7):519-25. PubMed ID: 18554311 [Abstract] [Full Text] [Related]
9. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Arslan M, Wiesner RH, Sievers C, Egan K, Zein NN. Liver Transpl; 2001 Apr 10; 7(4):314-20. PubMed ID: 11303291 [Abstract] [Full Text] [Related]
10. Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease. Aziz A, Aziz S, Li DS, Murphy L, Leone N, Kennedy M, Dhillon S, Van Thiel DH. J Viral Hepat; 2006 Apr 10; 13(4):217-21. PubMed ID: 16611186 [Abstract] [Full Text] [Related]
14. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study. Sapru A, Kulkarni PS, Bhave S, Bavdekar A, Naik SS, Pandit AN. J Trop Pediatr; 2007 Oct 10; 53(5):303-7. PubMed ID: 17478542 [Abstract] [Full Text] [Related]
16. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients. Ungulkraiwit P, Jongjirawisan Y, Atamasirikul K, Sungkanuparph S. Southeast Asian J Trop Med Public Health; 2007 Jul 10; 38(4):680-5. PubMed ID: 17883006 [Abstract] [Full Text] [Related]
19. Poor responses to recombinant HBV vaccination in patients with HIV infection. Pasricha N, Datta U, Chawla Y, Singh S, Arora SK, Sud A, Minz RW, Saikia B, Singh H, James I, Sehgal S. Trop Gastroenterol; 2005 Jul 10; 26(4):178-82. PubMed ID: 16737046 [Abstract] [Full Text] [Related]